These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18508949)

  • 1. Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy.
    Almeida L; Minciu I; Nunes T; Butoianu N; Falcão A; Magureanu SA; Soares-da-Silva P
    J Clin Pharmacol; 2008 Aug; 48(8):966-77. PubMed ID: 18508949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.
    Vaz da Silva M; Costa R; Soares E; Maia J; Falcão A; Almeida L; Soares da Silva P
    Fundam Clin Pharmacol; 2009 Aug; 23(4):509-14. PubMed ID: 19500154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker.
    Falcão A; Maia J; Almeida L; Mazur D; Gellert M; Soares-da-Silva P
    Biopharm Drug Dispos; 2007 Jul; 28(5):249-56. PubMed ID: 17443646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects.
    Nunes T; Sicard E; Almeida L; Falcão A; Rocha JF; Brunet JS; Lefebvre M; Soares-da-Silva P
    Curr Med Res Opin; 2010 Jun; 26(6):1355-62. PubMed ID: 20377319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and drug interactions of eslicarbazepine acetate.
    Bialer M; Soares-da-Silva P
    Epilepsia; 2012 Jun; 53(6):935-46. PubMed ID: 22612290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eslicarbazepine acetate for partial-onset seizures.
    Rauchenzauner M; Luef G
    Expert Rev Neurother; 2011 Dec; 11(12):1673-81. PubMed ID: 22091592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.
    Perucca E; Elger C; Halász P; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsy Res; 2011 Sep; 96(1-2):132-9. PubMed ID: 21680153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects.
    Almeida L; Nunes T; Sicard E; Rocha JF; Falcão A; Brunet JS; Lefebvre M; Soares-da-Silva P
    Acta Neurol Scand; 2010 Apr; 121(4):257-64. PubMed ID: 20047572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.
    Gil-Nagel A; Lopes-Lima J; Almeida L; Maia J; Soares-da-Silva P;
    Acta Neurol Scand; 2009 Nov; 120(5):281-7. PubMed ID: 19832771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers.
    Nunes T; Rocha JF; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Jan; 54(1):108-16. PubMed ID: 22812691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment.
    Almeida L; Potgieter JH; Maia J; Potgieter MA; Mota F; Soares-da-Silva P
    Eur J Clin Pharmacol; 2008 Mar; 64(3):267-73. PubMed ID: 18157705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.
    Shorvon SD; Trinka E; Steinhoff BJ; Holtkamp M; Villanueva V; Peltola J; Ben-Menachem E
    J Neurol; 2017 Mar; 264(3):421-431. PubMed ID: 28101651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate.
    Maia J; Almeida L; Falcão A; Soares E; Mota F; Potgieter MA; Potgieter JH; Soares-da-Silva P
    Int J Clin Pharmacol Ther; 2008 Mar; 46(3):119-30. PubMed ID: 18397682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of eslicarbazepine acetate in the corneal kindling progression and the amygdala kindling model of temporal lobe epilepsy.
    Potschka H; Soerensen J; Pekcec A; Loureiro A; Soares-da-Silva P
    Epilepsy Res; 2014 Feb; 108(2):212-22. PubMed ID: 24345645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters.
    Gidal BE; Mintzer S; Schwab M; Schutz R; Kharidia J; Blum D; Grinnell T; Sunkaraneni S
    Epilepsy Res; 2017 Sep; 135():64-70. PubMed ID: 28624574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate-A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome.
    Svendsen T; Brodtkorb E; Reimers A; Molden E; Sætre E; Johannessen SI; Johannessen Landmark C
    Epilepsy Res; 2017 Jan; 129():125-131. PubMed ID: 28043062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures.
    Sunkaraneni S; Ludwig EA; Passarell JA; Blum D; Grinnell T; Fiedler-Kelly J
    J Clin Pharmacol; 2018 Jul; 58(7):927-938. PubMed ID: 29528499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.